Spree Bar, a vaping system delivering a synthetic nicotine analogue, marketed in the USA as ‘PMTA exempt’-Reference-Cited by-同舟云学术

Spree Bar, a vaping system delivering a synthetic nicotine analogue, marketed in the USA as ‘PMTA exempt’

Published:2024-03-18 Issue: Volume: Page:tc-2023-058469
ISSN:0964-4563
Container-title:Tobacco Control
language:en
Short-container-title:Tob Control

Author:

Jordt Sven Eric^ORCID,Jabba Sairam V,Zettler Patricia J^ORCID,Berman Micah L^ORCID

Funder

National Institute on Drug Abuse (NIDA) / US Food and Drug Administration (FDA) Center for Tobacco Products

National Institute on Drug Abuse (NIDA) / US Food and Drug Administration (FDA) Center of Tobacco Products

National Cancer Institute

Publisher

BMJ

Reference41 articles.

1. Synthetic nicotine has arrived

2. Synthetic nicotine: science, global legal landscape, and regulatory considerations;Berman;World Health Organ Tech Rep Ser,2023

3. USFDA . New Law Clarifies FDA Authority to Regulate Synthetic Nicotine 2022, Available: https://www.fda.gov/tobacco-products/ctp-newsroom/new-law-clarifies-fda-authority-regulate-synthetic-nicotine [Accessed 10 Aug 2023].

4. USFDA . Regulation and enforcement of non-tobacco nicotine (NTN). Products 2023. Available: https://web.archive.org/web/20240204123107/https://www.fda.gov/tobacco-products/products-ingredients-components/regulation-and-enforcement-non-tobacco-nicotine-ntn-products [Accessed 28 Feb 2024].

5. USFDA. EVO Brands, LLC and PVG2, LLC d/b/a Puff Bar . 2022. Available: https://web.archive.org/web/20240212002446/www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evo-brands-llc-and-pvg2-llc-dba-puff-bar-643091-10062022 [Accessed 29 Feb 2024].

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues;JAMA;2024-09-03

2. 6‐Methylnicotine: a new nicotine alternative identified in e‐cigarette liquids sold in Australia;Medical Journal of Australia;2024-08-27

3. Marketing of nicotinamide as nicotine replacement in electronic cigarettes and smokeless tobacco;Tobacco Prevention & Cessation;2024-08-10

4. High Variability in Nicotine Analog Contents, Misleading Labeling, and Artificial Sweetener in New E-Cigarette Products Marketed as “FDA-Exempt”;2024-04-22